Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Innovate (VATE) over the last 16 years, with Q3 2025 value amounting to $17.0 million.

  • Innovate's Other Accumulated Expenses rose 429.45% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 429.45%. This contributed to the annual value of $17.2 million for FY2024, which is 683.23% up from last year.
  • Innovate's Other Accumulated Expenses amounted to $17.0 million in Q3 2025, which was up 429.45% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Innovate's Other Accumulated Expenses ranged from a high of $24.7 million in Q1 2023 and a low of $14.2 million during Q1 2021
  • Its 5-year average for Other Accumulated Expenses is $17.9 million, with a median of $17.2 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Innovate's Other Accumulated Expenses was 4186.05% (2021), while the steepest drop was 9969.09% (2021).
  • Over the past 5 years, Innovate's Other Accumulated Expenses (Quarter) stood at $18.3 million in 2021, then grew by 9.84% to $20.1 million in 2022, then decreased by 19.9% to $16.1 million in 2023, then increased by 6.83% to $17.2 million in 2024, then decreased by 1.16% to $17.0 million in 2025.
  • Its Other Accumulated Expenses stands at $17.0 million for Q3 2025, versus $17.2 million for Q2 2025 and $17.3 million for Q1 2025.